Escherichia coli is a common cause of infections in companion animals. In recent years the increasing prevalence of resistance to β-lactams, including extended-spectrum cephalosporins, antimicrobials frequently used in small animal veterinary practice, was observed in canine isolates of E. coli. The aim of this study was to detect and to characterize extended-spectrum β-lactamases (ESBLs) produced by E. coli isolated from diseased dogs in Poland. Four isolates out of 119 studied (3.4%) were ESBL-positive. They harbored the bla , bla , and bla genes. This study provides the first report of the occurrence of ESBL-producing E. coli in dogs in Poland.
Escherichia coli is an important opportunistic pathogen, causing in dogs mainly extraintestinal infections including those of urinary, respiratory and reproductive tracts. The antimicrobial resistance of E. coli occurring in companion animals, especially the multidrug resistance, becomes an emerging problem in veterinary medicine. The increasing percentage of multidrug resistant (MDR) E. coli isolation from dogs and cats in Poland, between 2007 and 2013, has been reported by Rzewuska et al. (2015) . The increase in the prevalence of resistance to β-lactams, such as aminopenicillins and extended-spectrum cephalosporins, was also observed in canine E. coli isolates. The β-lactam resistance in Enterobacteriaceae is associated mainly with production of enzymes hydrolyzing these antibiotics, among which the extended-spectrum β-lactamases (ESBLs), plasmidic AmpC β-lactamases and carbapenemases are the most important resistance mechanisms (Rubin and Pitout, 2014) . ESBLs mediate resistance to penicillins, cephalosporins and monobactams, but they are sensitive to β-lactam inhibitors. The presence of ESBLproducing E. coli in clinical specimens from dogs has been reported previously in some countries, such as the United States (O'Keefe et al., 2010; Shaheen et al., 2011) , the Netherlands (Dierikx et al., 2012; Hordijk et al., 2013) , Germany (Schmiedel et al., 2014) , Italy (Carattoli et al., 2005) and Korea (So et al., 2012) . However, detailed information about properties of ESBLs occurring in canine E. coli and their geographic distribution are still limited. To our knowledge, there are no published data regarding the occurrence of ESBLs in canine E. coli in Poland.
The aim of the study was to detect and to characterize ESBLs in E. coli isolated from diseased dogs in Poland.
E. coli isolates (n = 119) investigated in this study were obtained from clinical samples collected from diseased dogs. The isolates were identified using standard microbiological diagnostic techniques. Antimicrobial susceptibility was determined by the disk diffusion method, as described previously (Rzewuska et al., 2015) . E. coli ATCC 25922 was used as a quality control.
The phenotypic test using ceftazidime and ceftazidime/clavulanic acid disks (Becton Dickinson) was performed according to the Clinical and Laboratory Standards Institute guidelines (CLSI, 2013) those isolates were screened for the bla CMY-2 gene, as the activity of β-lactamase CMY-2 could mask the ESBLpositive phenotype (Thomson, 2010) . The PCR assays were performed using primers (Genomed, Poland) and reaction conditions described previously (Table I) . DNA was isolated using Genomic Mini kit (A&A Biotechnology, Poland) according to the manufacturer's recommendations. In order to identify the type of genes detected, the obtained amplicons were purified with the GeneJET TM PCR Purification Kit (Thermo-Scientific) according to the manufacturer's recommendations, and sequenced using the same primers and a 3730 xl DNA Analyzer (Applied Biosystems, USA). Sequencing files were evaluated using the Chromas Lite version 2.33 program (Technelysium Pty Ltd., Australia). Subsequently, the nucleotide sequences were compared to the sequences in the GenBank database using BLAST (http://blast.ncbi.nlm.nih.gov). Additionally, the bla TEM nucleotide sequences were translated into protein sequences, and then aligned with the reference sequence of TEM-1 β-lactamase (GenBank Accession Number J01749) by MEGA version 5.0. On the basis of the amino acid substitutions found and the TEM mutation table (http://www.lahey.org/Studies/temtable.asp), the type of TEM β-lactamase was determined for each bla TEM gene detected.
ESBL-producing E. coli was detected among the studied isolates, and this is the first report on the presence of this bacterium in dogs in Poland. The ESBLpositive phenotype was found in four E. coli isolates from extraintestinal infections in dogs. Characteristics of these isolates are presented in Table II . Genes of three different ESBLs were detected and identified, as bla , bla , and bla . The fourth gene whose presence was assayed, bla CMY-2 encoding a plasmidic class C β-lactamase CMY-2, was not found in any of those isolates.
In the present study all ESBL-producing E. coli isolates were classified as MDR bacteria, showing resistance to at least three antimicrobial classes (Table III) . Multidrug resistance has been also observed in ESBLpositive E. coli of various origin in other studies (Schmiedel et al., 2014; Shaheen et al., 2011) .
The occurrence of ESBL-producing E. coli in dogs, ranging from 1% to 33.3%, has been reported previously (Dierikx et al., 2012; Ewers et al., 2010; Hordijk et al., 2013; Huber et al., 2013; O'Keefe et al., 2010; Schmiedel et al., 2014; Shaheen et al., 2011; So et al., 2012) . Ewers et al. (2010) reported that ESBL-producing E. coli was isolated from 10.7% of clinical samples collected from dogs. The high prevalence (33.3%) of these bacteria isolated from rectal swabs of hospitalized dogs in Korea was reported by So et al. (2012) . In our study, only 3.4% (4/119 isolates) of studied E. coli isolates were ESBL-positive. These findings correspond with the observations of Shaheen et al. (2011) United States and Huber et al. (2013) in Switzerland, where the frequency of ESBL-producing E. coli isolation from dogs, mainly from urinary tract infections, was 3% and 3.3%, respectively. Three different types of ESBLs were found in the studied E. coli isolates (Table II) . The β-lactamase CTX-M-15, detected in three isolates, belongs to the CTX-M-1 group and represents the most frequently reported ESBL type in E. coli isolates of canine and feline origin (Ewers et al., 2010; Huber et al., 2013; O'Keefe et al., 2010; Schmiedel et al., 2014; Shaheen et al., 2011) . The other ESBL, SHV-12, detected in one of the studied isolates, has rarely been found in E. coli isolated from dogs (Carattoli et al., 2005; Ewers et al., 2010; O'Keefe et al., 2010) . Furthermore, in all ESBL-positive isolates the gene encoding the TEM-116 β-lactamase was detected. This enzyme is TEM-1 derivative with ESBL activity, and occurs in various species of Enterobacteriaceae isolated from humans (Dhara et al., 2013) . This is only the second report of TEM-116 β-lactamase in E. coli of canine origin, the first being that of Ewers et al. (2010) .
In this study ESBL-producing E. coli strains were isolated from diseased dogs with extraintestinal infections. However, they have also been detected in faecal samples of healthy dogs and cats (Belas et al., 2014; Hordijk et al., 2013) , and it seems that companion animals could be asymptomatic carriers of these bacteria.
The β-lactams are antimicrobial drugs commonly used in small animal veterinary practice (Murphy et al., 2012) . The β-lactamases, which mediate the β-lactam resistance, are most often encoding by genes grouped in cassettes and located on mobile genetic elements, such as plasmids and transposons, so they may be extensively transmitted between different bacteria. Therefore inappropriate usage of β-lactams may contribute to the development of broad-spectrum resistance and to the dissemination of multiresistant strains among humans and animals. Our study showed that dogs in Poland can be a potential reservoir of ESBL-positive E. coli, though the prevalence of these bacteria in clinical specimen was relatively low. The results suggest that the ESBL production is probably not a main mechanism of resistance to β-lactams in the studied E. coli population. However, the further investigation should explain a role of other resistance mechanisms in E. coli of canine origin. 
